Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 1,665 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Type I Diabetes Clear all

Conditions: Diabetes Mellitus, Type 1
Interventions: Online Learning Modules; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 2 Years to 17 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Diabetes Mellitus, Type 1 Diabetes, Insulin Pump
Interventions: t:slim insulin pump with predictive low glucose suspend; Device
Lead sponsor: Tandem Diabetes Care, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 2
States / cities: Palo Alto, California • Aurora, Colorado

Conditions: Implementation Science, Type 1 Diabetes in Adolescence, Implementation Strategies
Interventions: Base Implementation Toolkit (BIT), BIT-Enhanced, BIT-Sustainment; Behavioral
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Diabetes Mellitus, Type 1
Interventions: Empagliflozin, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 34
States / cities: Escondido, California • Huntington Beach, California • Los Angeles, California + 31 more

Conditions: Diabetes Mellitus, Type 1
Interventions: Planet T1D; Behavioral
Lead sponsor: 3-C Institute for Social Development; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Insulin Hypoglycemia, Type 1 Diabetes Mellitus, Severe Hypoglycemia
Interventions: G-Pen, Novo Glucagon; Drug
Lead sponsor: Xeris Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Walnut Creek, California • Atlanta, Georgia • Las Vegas, Nevada + 1 more

Conditions: Type2 Diabetes, Type1diabetes, Insulin Dependent Diabetes
Interventions: No treatment; Device
Lead sponsor: Abbott Diabetes Care; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Walnut Creek, California • Rainier, Washington

Conditions: Type 1 Diabetes, Type 2 Diabetes, Metabolic Syndrome
Interventions: Not listed
Lead sponsor: University of California, Irvine; Other
Eligibility: 40 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Irvine, California

Conditions: Type 1 Diabetes (T1D)
Interventions: BREATHE-T1D, HealthEd-T1D; Behavioral
Lead sponsor: Children's National Research Institute; Other
Eligibility: 13 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Aurora, Colorado • Washington D.C., District of Columbia

Conditions: Diabetes Mellitus, Type 1
Interventions: Allogenic islet cells (human, U. Chicago), Intraportal infusion of islet cells; Biological · Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 68 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Type 1 Diabetes
Interventions: Sleep Extension, Routine; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 10 Years to 17 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Hypoglycemia
Interventions: G-Pen Mini™ (glucagon injection); Drug
Lead sponsor: Xeris Pharmaceuticals; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 1 Diabetes
Interventions: Exercise; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Diabetes
Interventions: Extended Infusion Set; Device
Lead sponsor: Medtronic MiniMed, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 15
States / cities: Little Rock, Arkansas • Escondido, California • Palo Alto, California + 12 more

Conditions: Diabetes, Diabetes Mellitus, Type 1
Interventions: insulin degludec/insulin aspart, insulin aspart, insulin detemir; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 1 Year to 17 Years
Enrollment: 362 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 24
States / cities: Phoenix, Arizona • Tucson, Arizona • Sacramento, California + 19 more

Conditions: Pancreatic Cancer
Interventions: Ipilimumab, Pancreatic Cancer Vaccine; Drug · Biological
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypoglycemia, Diabetes Mellitus, Drug-Specific Antibodies
Interventions: Nasal Glucagon; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 3
States / cities: Waltham, Massachusetts • Minneapolis, Minnesota • Albany, New York

Conditions: Type 1 Diabetes Mellitus
Interventions: Predictive Low Glucose Suspend Algorithm ON, Predictive Low Glucose Suspend Algorithm OFF; Device
Lead sponsor: Stanford University; Other
Eligibility: 12 Years to 46 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Stanford, California • Aurora, Colorado

Conditions: Type 1 Diabetes (T1D), Sleep Health
Interventions: Sleep Health and Circadian Timing Intervention; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 14 Years to 19 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Chronic Kidney Diseases, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Interventions: Renal Autologous Cell Therapy (REACT); Biological
Lead sponsor: Prokidney; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: Denver, Colorado • Newark, Delaware • Nampa, Idaho + 2 more

Conditions: Type 1 Diabetes
Interventions: Exenatide, Rapid and long acting insulin, long acting insulin + rapid acting + 1.25 mcg Exenatide; Drug
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 12 Years to 18 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Type 1 Diabetes Mellitus
Interventions: Rilonacept; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 16 Years to 45 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 1 Diabetes
Interventions: Upper endoscopy with small bowel biopsies and brushings., Blood draw, Stool sample; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 60 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Type 1 Diabetes
Interventions: neurocognitive assessment, neuroimaging assessment; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 6 Years to 11 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee